These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11961730)

  • 1. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
    Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
    Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Costs of ambulant care for patients with inflammatory bowel disease in general practice].
    Beiche A; König HH; Ebinger M; Matysiak-Klose D; Braun V; Leidl R
    Z Gastroenterol; 2003 Jun; 41(6):527-36. PubMed ID: 12806538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost evaluation by a patient questionnaire: pilot study of a weekly cost diary].
    Becker A; Seitz R; Jacobi E; Leidl R
    Rehabilitation (Stuttg); 2001 Feb; 40(1):12-20. PubMed ID: 11253749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
    Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
    Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct costs related to rheumatoid arthritis: the patient perspective.
    Hülsemann JL; Mittendorf T; Merkesdal S; Handelmann S; von der Schulenburg JM; Zeidler H; Ruof J
    Ann Rheum Dis; 2005 Oct; 64(10):1456-61. PubMed ID: 15800007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
    van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
    Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost of early management of chronic inflammatory intestinal disease].
    Rolland N; Grandbastien B; Merle V; Gower-Rousseau C; Yzet T; Marti R; Lerebours E; Dupas JL; Czernichow P; Salomez JL; Lebrun T; Cortot A
    Gastroenterol Clin Biol; 1999 Apr; 23(4):483-8. PubMed ID: 10416112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and quality of life of multiple sclerosis in Germany.
    Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and indirect costs attributable to osteoarthritis in active subjects.
    Rabenda V; Manette C; Lemmens R; Mariani AM; Struvay N; Reginster JY
    J Rheumatol; 2006 Jun; 33(6):1152-8. PubMed ID: 16755664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
    Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
    Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey.
    Longobardi T; Jacobs P; Wu L; Bernstein CN
    Am J Gastroenterol; 2003 Apr; 98(4):844-9. PubMed ID: 12738466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial.
    Van Tubergen A; Boonen A; Landewé R; Rutten-Van Mölken M; Van Der Heijde D; Hidding A; Van Der Linden S
    Arthritis Rheum; 2002 Oct; 47(5):459-67. PubMed ID: 12382292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
    Delong LK; Culler SD; Saini SS; Beck LA; Chen SC
    Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.